| Literature DB >> 34165204 |
Christina K Rapp1, Ine Van Dijck2, Lucia Laugwitz3,4, Mieke Boon2, George Briassoulis5, Stavroula Ilia5, Birgit Kammer6, Simone Reu7, Stefanie Hornung8, Rebecca Buchert3, Linda Sofan3, Tawfiq Froukh9, Peter Witters10, Daisy Rymen10, Tobias B Haack7,11, Marijke Proesmans2, Matthias Griese1.
Abstract
Fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA, MIM#618278) is a rare clinical condition caused by bi-allelic variants in NHL repeat containing protein 2 (NHLRC2, MIM*618277). Pulmonary disease may be the presenting sign and the few patients reported so far, all deceased in early infancy. Exome sequencing was performed on patients with childhood interstitial lung disease (chILD) and additional neurological features. The chILD-EU register database and an in-house database were searched for patients with NHLRC2 variants and clinical features overlapping FINCA syndrome. Six patients from three families were identified with bi-allelic variants in NHLRC2. Two of these children died before the age of two while four others survived until childhood. Interstitial lung disease was pronounced in almost all patients during infancy and stabilized over the course of the disease with neurodevelopmental delay (NDD) evolving as the key clinical finding. We expand the phenotype of FINCA syndrome to a multisystem disorder with variable severity. FINCA syndrome should also be considered in patients beyond infancy with NDD and a history of distinct interstitial lung disease. Managing patients in registers for rare diseases helps identifying new diagnostic entities and advancing care for these patients.Entities:
Keywords: FINCA; NHLRC2; cerebropulmonary disease; childhood interstitial lung disease; cholesterol pneumonia; lipoid pneumonitis; lung fibrosis; multi-organ disease
Mesh:
Substances:
Year: 2021 PMID: 34165204 DOI: 10.1111/cge.14016
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438